ReviewNeurology2022

Who to Enroll in Parkinson Disease Prevention Trials? The Case for Genetically At-Risk Cohorts.

Kellyann Niotis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.